<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Russian Journal of Skin and Venereal Diseases</journal-id><journal-title-group><journal-title xml:lang="en">Russian Journal of Skin and Venereal Diseases</journal-title><trans-title-group xml:lang="ru"><trans-title>Российский журнал кожных и венерических болезней</trans-title></trans-title-group></journal-title-group><issn publication-format="print">1560-9588</issn><issn publication-format="electronic">2412-9097</issn><publisher><publisher-name xml:lang="en">Eco-Vector</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">706527</article-id><article-id pub-id-type="doi">10.17816/dv706527</article-id><article-id pub-id-type="edn">PHIVLL</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>DERMATOLOGY</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>ДЕРМАТОЛОГИЯ</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Primary incidence of psoriasis in the Russian Federation</article-title><trans-title-group xml:lang="ru"><trans-title>Первичная заболеваемость псориазом населения Российской Федерации</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-7714-7970</contrib-id><contrib-id contrib-id-type="spin">1518-2481</contrib-id><name-alternatives><name xml:lang="en"><surname>Ivanova</surname><given-names>Maisa A.</given-names></name><name xml:lang="ru"><surname>Иванова</surname><given-names>Маиса Афанасьевна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, Dr. Sci. (Medicine), Professor</p></bio><bio xml:lang="ru"><p>д-р мед. наук, профессор</p></bio><email>maisa@mednet.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1669-939X</contrib-id><contrib-id contrib-id-type="spin">5759-6597</contrib-id><name-alternatives><name xml:lang="en"><surname>Terentyeva</surname><given-names>Dina S.</given-names></name><name xml:lang="ru"><surname>Терентьева</surname><given-names>Дина Станиславовна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>terentyeva@mednet.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6696-8714</contrib-id><contrib-id contrib-id-type="spin">2092-5448</contrib-id><name-alternatives><name xml:lang="en"><surname>Polikarpov</surname><given-names>Alexandr V.</given-names></name><name xml:lang="ru"><surname>Поликарпов</surname><given-names>Александр Викторович</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, Dr. Sci. (Medicine)</p></bio><bio xml:lang="ru"><p>д-р мед. наук</p></bio><email>polikarpov@mednet.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4427-3900</contrib-id><contrib-id contrib-id-type="spin">9998-9653</contrib-id><name-alternatives><name xml:lang="en"><surname>Penkina</surname><given-names>Nadezhda I.</given-names></name><name xml:lang="ru"><surname>Пенкина</surname><given-names>Надежда Ильинична</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, Dr. Sci. (Medicine), Professor</p></bio><bio xml:lang="ru"><p>д-р мед. наук, профессор</p></bio><email>nad.penkina@yandex.ru</email><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0002-3766-7039</contrib-id><name-alternatives><name xml:lang="en"><surname>Rahal</surname><given-names>Alaa Aldin Y.</given-names></name><name xml:lang="ru"><surname>Рахал</surname><given-names>Алаа Алдин Юсеф Махмуд</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>Aladin.rahal@mail.ru</email><xref ref-type="aff" rid="aff3"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Central Scientific Research Institute for Healthcare Organization and Informatization</institution></aff><aff><institution xml:lang="ru">Центральный научно-исследовательский институт организации и информатизации здравоохранения</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">Izhevsk State Medical University</institution></aff><aff><institution xml:lang="ru">Ижевский государственный медицинский университет</institution></aff></aff-alternatives><aff-alternatives id="aff3"><aff><institution xml:lang="en">The First Sechenov Moscow State Medical University (Sechenov University)</institution></aff><aff><institution xml:lang="ru">Первый Московский государственный медицинский университет имени И.М. Сеченова (Сеченовский Университет)</institution></aff></aff-alternatives><pub-date date-type="preprint" iso-8601-date="2026-07-07" publication-format="electronic"><day>07</day><month>07</month><year>2026</year></pub-date><pub-date date-type="pub" iso-8601-date="2026-09-10" publication-format="electronic"><day>10</day><month>09</month><year>2026</year></pub-date><volume>29</volume><issue>4</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>473</fpage><lpage>479</lpage><history><date date-type="received" iso-8601-date="2026-04-21"><day>21</day><month>04</month><year>2026</year></date><date date-type="accepted" iso-8601-date="2026-06-09"><day>09</day><month>06</month><year>2026</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2026, Eco-Vector</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2026, Эко-Вектор</copyright-statement><copyright-year>2026</copyright-year><copyright-holder xml:lang="en">Eco-Vector</copyright-holder><copyright-holder xml:lang="ru">Эко-Вектор</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/" start_date="2029-09-10"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://eco-vector.com/for_authors.php#07</ali:license_ref></license></permissions><self-uri xlink:href="https://rjsvd.com/1560-9588/article/view/706527">https://rjsvd.com/1560-9588/article/view/706527</self-uri><abstract xml:lang="en"><p><bold>BACKGROUND:</bold> Psoriasis is a chronic multifactorial dermatosis that poses a serious medical and social problem. It occurs with virtually equal frequency in women and men, and there is a hereditary predisposition to its development. The most significant factors in the development of psoriasis are considered to be ethnicity, genetics, and environmental factors, although immune disorders are also possible. Psoriasis, as a disease associated with various comorbidities, including cardiovascular, gastrointestinal, endocrine, and other systems and organs, often causes persistent disability. Early detection and prevention of relapses are an important strategic task for medical specialists.</p> <p><bold>AIM:</bold> To assess the primary incidence of psoriasis in the Russian Federation.</p> <p><bold>METHODS: </bold>An analysis of federal statistical observation forms for 2020–2024, presented in collections of the Ministry of Health of the Russian Federation, was conducted. Primary psoriasis incidence rates in the Russian Federation were calculated.</p> <p><bold>RESULTS:</bold> The study revealed that the average Russian incidence rate of psoriasis for the study period, both in the Russian Federation as a whole and in most federal districts, is trending upward, despite a decline in 2024 compared to the previous year. This upward trend in psoriasis incidence is characteristic of both adults and children. The most unfavorable situation for the general population is found in the Northwestern and Volga Federal Districts, and for children, in the Northwestern and Far Eastern Federal Districts.</p> <p><bold>CONCLUSION:</bold> An increase in primary psoriasis incidence in the Russian Federation was revealed for both adults and children. This indicates the need to study the causes of this increase in incidence and make management decisions on psoriasis prevention among the population.</p></abstract><trans-abstract xml:lang="ru"><p><bold>Обоснование.</bold> Псориаз относится к хроническим мультифакториальным дерматозам, представляющим серьёзную медико-социальную проблему. У женщин и мужчин заболевание встречается практически с одинаковой частотой, при этом имеется наследственная предрасположенность к его развитию. Наиболее значимыми факторами развития псориаза считают этническую, генетическую принадлежность и действие факторов внешней среды, хотя не исключаются и иммунные нарушения. Псориаз как заболевание, ассоциированное с различными сопутствующими заболеваниями, включая сердечно-сосудистую, желудочно-кишечную, эндокринную и другие системы и органы организма, нередко становится причиной стойкой утраты трудоспособности. Раннее выявление и профилактика рецидивов являются важной стратегической задачей врачей-специалистов.</p> <p><bold>Цель исследования</bold> ― изучить первичную заболеваемость псориазом населения Российской Федерации.</p> <p><bold>Методы.</bold> Проведён анализ данных форм федерального статистического наблюдения за 2020–2024 годы, представленных в сборниках Министерства здравоохранения Российской Федерации. Рассчитаны показатели первичной заболеваемости псориазом в Российской Федерации.</p> <p><bold>Результаты.</bold> В процессе исследования установлено, что среднероссийский показатель заболеваемости псориазом за исследуемый период как в целом по Российской Федерации, так и в большинстве федеральных округов имеет тенденцию к росту, несмотря на его снижение в 2024 году относительно предыдущего года. Тенденция к росту заболеваемости псориазом характерна как для взрослых, так и для детей. Самая неблагополучная ситуация по заболеваемости псориазом всего населения сложилась в Северо-Западном и Приволжском, детского населения ― в Северо-Западном и Дальневосточном федеральных округах.</p> <p><bold>Заключение.</bold> Рост первичной заболеваемости псориазом в Российской Федерации выявлен как для взрослых, так и для детей, что свидетельствует о необходимости изучения причин роста заболеваемости и принятия управленческих решений по профилактике псориаза среди населения.</p></trans-abstract><kwd-group xml:lang="en"><kwd>childhood</kwd><kwd>psoriasis</kwd><kwd>diagnosis</kwd><kwd>primary psoriasis incidence</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>детский возраст</kwd><kwd>псориаз</kwd><kwd>диагностика</kwd><kwd>первичная заболеваемость псориазом</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Potekaev NN, Lvov AN, Zhukova OV, et al. Psychosomatic disorders and quality of life in patients with chronic facial dermatoses and their dynamics with underlying application of medical camouflage. Klinicheskaya dermatologiya i venerologiya. 2017;16(5):58–72. doi: 10.17116/klinderma201716558-71 EDN: ZTSVCT</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Sarsus SH, Rudneva NS. Modern clinical and epidemiological features of psoriasis. 2025;(6):96. Sovremennye problemy nauki i obrazovaniya. doi: 10.17513/spno.34424 EDN: ATRAEB</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Picard C, Gaspard HB, Al-Hertz W, et al. International Union of Immunological Societies: 2017 Primary immunodeficiency diseases committee report on inborn errors of immunity. J Clin Immunol. 2018;38(1):96–128. doi: 10.1007/s10875-017-0464-9 EDN: VOZOQC</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Leutenegger AL, Sahbatu M, Gazal S, et al. Consanguinity around the world: what do the genomic data of the HGDP-CEPH diversity panel tell us? Eur J Hum Genet. 2011;19(5):583–587. doi: 10.1038/ejhg.2010.205</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Akimov VG, Akhtyamov SN, Batkaev EA, et al. Clinical dermatovenerology: a guide for doctors: in 2 vol. Skripkina YuK, Butova YS, editors. Vol. 2. Moscow: GEOTAR-Media; 2009. P. 212–233. (In Russ.) EDN: QLTIHX</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Kubanov AA, Bogdanova EV. Epidemiology of psoriasis in the russian federation according to the patient registry. Vestnik dermatologii i venerologii. 2022;98(1):33–41. doi: 10.25208/vdv1268 EDN: FMVIJC</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Damiani G, Bragazzi NL, Aksut SK, et al. The global, regional, and national burden of psoriasis: results and insights from the global burden of disease 2019 study. Front Med (Lausanne). 2021;8:743180. doi: 10.3389/fmed.2021.743180 EDN: VLKMDK</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Zagrtdinova PM. Filimonov MA, Trusov VV, et al. Functional disturbances of the hepatobiliary system in psoriatic patients and prospects of their correction. Vestnik dermatologii i venerologii. 2006;(3):13–15. EDN: ISDUMX</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Zagrtdinova RM, Filimonov MA, Ivanova MA, Orlov SA. The pituitary-thyroid system in patients with psoriasis. Russian journal of skin and venereal diseases. 2006;(2):20–24. EDN: HTGLPV</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Dvoryankova EV, Novozinskaya ZA, Vaal OV, et al. Key aspects of paediatric psoriasis. Doctor.ru. 2020;19(10):16–21. doi: 10.31550/1727-2378-2020-19-10-16-21 EDN: EHYUHF</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Bogdanova EV, Kubanov AA. Relationship between the prevalence of cardiometabolic diseases and the presence of psoriatic arthritis in Russian patients with psoriasis. Modern rheumatology journal. 2023;17(2):37–43. doi: 10.14412/1996-7012-2023-2-37-43 EDN: UKLSZG</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Batkaeva NV, Olisova OYu, Batkaev EA. Pathogenetic approaches to the treatment of psoriasis and comorbid pathology. Post-qualifying medical education herald. 2025;(1):29–36. EDN: VVWLRU</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Batkaeva NV, Olisova OYu, Batkaev EA. Diagnosis psoriasis and psoriatic arthritis at the present stage. Post-qualifying medical education herald. 2024;(2):23–30. EDN: AAXLIV</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Batkaeva NV, Olisova OYu, Batkaev EA. Psoriasis and metabolic syndrome: the role of diet therapy and nutritional supplements (current state of the issue). Post-qualifying medical education herald. 2024;(3):3–11. EDN: GWWIED</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Olisova OYu, Kochergin NG, Yatskova OS, Brezhneva AA. Phototherapy and biological for psoriasis: advantages and disadvantages. Effective pharmacotherapy. 2024;20(28):68–77. doi: 10.33978/2307-3586-2024-20-28-68-77 EDN: DCHTTZ</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Parisi R, Symmons DP, Griffiths CE, Ashcroft DM. Global epidemiology of psoriasis: a systematic review of incidence and prevalence. J Invest Dermatol. 2013;133(2):377–385. doi: 10.1038/jid.2012.339</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Kotova EG, Kobyakova OS, Kubanov AA, et al. Resources and activities of medical organizations of dermatovenerological profile. Incidence of sexually transmitted infections, infectious skin diseases and skin diseases in 2021: statistical materials. Moscow; 2022. 213 р. (In Russ.) doi: 10.21045/978-5-94116-101-0 EDN: VXBLTS</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Deev IA, Kobyakova OS, Kubanov AA, et al. Resources and performance of dermatovenereological medical organizations. The incidence of sexually transmitted infections, contagious skin diseases and diseases of the skin in 2023: statistical materials. Moscow; 2024. 208 p. (In Russ.)</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Deev IA, Kobyakova OS, Kubanov AA, et al. Resources and performance of dermatovenereological medical organizations. The incidence of sexually transmitted infections, contagious skin diseases and diseases of the skin in 2024: statistical materials. Moscow; 2025. 207 p. (In Russ.)</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Umerova AR, Dorfman IL, Dumchenko VV, Makukhina LP. Modern approaches to the treatment of psoriasis in children and adolescents. Russkii meditsinskii zhurnal. 2015;23(19):1156–1158. (In Russ.) EDN: TDXJIK</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Kochergin SN, Tamrazova OB, Stadnikova AS. Psoriasis in children and adolescents. Consilium medicum: Pediatrics. 2016;(2):77–81. EDN: WJGNRH</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Farber EM, Nall ML. Epidemiology: natural history and genetics. In: Roenigk HH, Maibach HI, editors. Psoriasis. 3rd ed. New York: Marcel Dekker; 1998. Р. 107–115.</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Raychaudhuri AP, Gross J. A comparative study of pediatric onset psoriasis with adult onset psoriasis. Pediatr Dermatol. 2000;17(3):174–178. doi: 10.1046/j.1525-1470.2000.01746.x</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Bagaeva AM, Nashkhoev MR, Madyanova VV, Toskin IA. The comparative characteristic of approaches to monitoring and evaluation of morbidity of psoriasis in the Russian Federation and the countries of the European region. Problems of Social Hygiene, Public Health and History of Medicine. 2021;29(1):59–65. doi: 10.32687/0869-866X-2021-29-1-59-65 EDN: MMOOWR</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>Kungurov NV, Kohan MM, Syrneva TA, et al. Features and trends of the incidence and prevalence of psoriasis in the subjects of the Russian Federation for the period 2009–2017. International journal of applied and fundamental research. 2021;(8):9–15. doi: 10.17513/mjpfi.13255</mixed-citation></ref></ref-list></back></article>
